Publications by authors named "Matthew J Tozer"

Claim this Profile
D
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
Jean-Olivier Zirimwabagabo, Ameera B A Jailani, Paris Avgoustou, Matthew J Tozer, Karl R Gibson

J Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.
Paris Avgoustou, Ameera B A Jailani, Jean-Olivier Zirimwabagabo, Matthew J Tozer, Karl R Gibson

ACS Pharmacol Transl Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of (binap)(enyne)tetracarbonyldicobalt(0) complexes.
Susan E Gibson, David J Hardick, Peter R Haycock, Karina A C Kaufmann, Ayako Miyazaki, Matthew J Tozer

Chemistry· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
Ildiko M Buck, James W Black, Tracey Cooke, David J Dunstone, John D Gaffen, Matthew J Tozer

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New routes to beta-cycloalkylalanine derivatives using serine-derived organozinc reagents.
Tomas Carrillo-Marquez, Lorenzo Caggiano, Richard F W Jackson, Urszula Grabowska, Alastair Rae, Matthew J Tozer

Org Biomol Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structural analysis of dehydrophenylalanine cyclophanes.
Susan E Gibson, Jerome O Jones, S Barret Kalindjian, Jamie D Knight, Jonathan W Steed, Matthew J Tozer

Chem Commun (Camb)· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCK(2) receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic.
Susan E Gibson, Nathalie Guillo, Jerome O Jones, Ildiko M Buck, S Barret Kalindjian, Matthew J Tozer

Eur J Med Chem· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
Matthew J Tozer, Ildiko M Buck, Tracey Cooke, S Barret Kalindjian, Michael J Pether

Bioorg Med Chem· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis